189 related articles for article (PubMed ID: 21715310)
21. MicroRNA expression profiles in Kaposi's sarcoma.
Catrina Ene AM; Borze I; Guled M; Costache M; Leen G; Sajin M; Ionica E; Chitu A; Knuutila S
Pathol Oncol Res; 2014 Jan; 20(1):153-9. PubMed ID: 24027049
[TBL] [Abstract][Full Text] [Related]
22. The SH3BGR/STAT3 Pathway Regulates Cell Migration and Angiogenesis Induced by a Gammaherpesvirus MicroRNA.
Li W; Yan Q; Ding X; Shen C; Hu M; Zhu Y; Qin D; Lu H; Krueger BJ; Renne R; Gao SJ; Lu C
PLoS Pathog; 2016 Apr; 12(4):e1005605. PubMed ID: 27128969
[TBL] [Abstract][Full Text] [Related]
23. Kaposi's sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 suppresses CXCR4 expression by upregulating miR-146a.
Punj V; Matta H; Schamus S; Tamewitz A; Anyang B; Chaudhary PM
Oncogene; 2010 Mar; 29(12):1835-44. PubMed ID: 20023696
[TBL] [Abstract][Full Text] [Related]
24. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen prolongs the life span of primary human umbilical vein endothelial cells.
Watanabe T; Sugaya M; Atkins AM; Aquilino EA; Yang A; Borris DL; Brady J; Blauvelt A
J Virol; 2003 Jun; 77(11):6188-96. PubMed ID: 12743275
[TBL] [Abstract][Full Text] [Related]
25. Transcription profile of Kaposi's sarcoma-associated herpesvirus in primary Kaposi's sarcoma lesions as determined by real-time PCR arrays.
Dittmer DP
Cancer Res; 2003 May; 63(9):2010-5. PubMed ID: 12727810
[TBL] [Abstract][Full Text] [Related]
26. Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNAs promote matrix metalloproteinases (MMPs) expression and pro-angiogenic cytokine secretion in endothelial cells.
Guo Y; Li W; Qin J; Lu C; Fan W
J Med Virol; 2017 Jul; 89(7):1274-1280. PubMed ID: 28165144
[TBL] [Abstract][Full Text] [Related]
27. Latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells activates hypoxia-induced factors.
Carroll PA; Kenerson HL; Yeung RS; Lagunoff M
J Virol; 2006 Nov; 80(21):10802-12. PubMed ID: 16956952
[TBL] [Abstract][Full Text] [Related]
28. A functional genomics approach to Kaposi's sarcoma.
Moses AV; Jarvis MA; Raggo C; Bell YC; Ruhl R; Luukkonen BG; Griffith DJ; Wait CL; Druker BJ; Heinrich MC; Nelson JA; Fruh K
Ann N Y Acad Sci; 2002 Dec; 975():180-91. PubMed ID: 12538164
[TBL] [Abstract][Full Text] [Related]
29. The complete Kaposi sarcoma-associated herpesvirus genome induces early-onset, metastatic angiosarcoma in transgenic mice.
Sin SH; Eason AB; Kim Y; Schneider JW; Damania B; Dittmer DP
Cell Host Microbe; 2024 May; 32(5):755-767.e4. PubMed ID: 38653242
[TBL] [Abstract][Full Text] [Related]
30. Endothelial cell- and lymphocyte-based in vitro systems for understanding KSHV biology.
McAllister SC; Moses AV
Curr Top Microbiol Immunol; 2007; 312():211-44. PubMed ID: 17089799
[TBL] [Abstract][Full Text] [Related]
31. Cellular microRNA-127-3p suppresses oncogenic herpesvirus-induced transformation and tumorigenesis via down-regulation of SKP2.
Lee SM; Kaye KM; Slack FJ
Proc Natl Acad Sci U S A; 2021 Nov; 118(45):. PubMed ID: 34725152
[TBL] [Abstract][Full Text] [Related]
32. The M type K15 protein of Kaposi's sarcoma-associated herpesvirus regulates microRNA expression via its SH2-binding motif to induce cell migration and invasion.
Tsai YH; Wu MF; Wu YH; Chang SJ; Lin SF; Sharp TV; Wang HW
J Virol; 2009 Jan; 83(2):622-32. PubMed ID: 18971265
[TBL] [Abstract][Full Text] [Related]
33. Altered patterns of cellular gene expression in dermal microvascular endothelial cells infected with Kaposi's sarcoma-associated herpesvirus.
Poole LJ; Yu Y; Kim PS; Zheng QZ; Pevsner J; Hayward GS
J Virol; 2002 Apr; 76(7):3395-420. PubMed ID: 11884566
[TBL] [Abstract][Full Text] [Related]
34. KSHV manipulates Notch signaling by DLL4 and JAG1 to alter cell cycle genes in lymphatic endothelia.
Emuss V; Lagos D; Pizzey A; Gratrix F; Henderson SR; Boshoff C
PLoS Pathog; 2009 Oct; 5(10):e1000616. PubMed ID: 19816565
[TBL] [Abstract][Full Text] [Related]
35. Human herpesvirus 8/Kaposi sarcoma herpesvirus cell association during evolution of Kaposi sarcoma.
Pyakurel P; Massambu C; Castaños-Vélez E; Ericsson S; Kaaya E; Biberfeld P; Heiden T
J Acquir Immune Defic Syndr; 2004 Jun; 36(2):678-83. PubMed ID: 15167286
[TBL] [Abstract][Full Text] [Related]
36. miRNAs and their roles in KSHV pathogenesis.
Hussein HAM; Alfhili MA; Pakala P; Simon S; Hussain J; McCubrey JA; Akula SM
Virus Res; 2019 Jun; 266():15-24. PubMed ID: 30951791
[TBL] [Abstract][Full Text] [Related]
37. Identification of Target Genes Regulated by KSHV miRNAs in KSHV-Infected Lymphoma Cells.
Quan L; Qiu T; Liang J; Li M; Zhang Y; Tao K
Pathol Oncol Res; 2015 Sep; 21(4):875-80. PubMed ID: 25648438
[TBL] [Abstract][Full Text] [Related]
38. Role of heme oxygenase-1 in the pathogenesis and tumorigenicity of Kaposi's sarcoma-associated herpesvirus.
Dai L; Qiao J; Nguyen D; Struckhoff AP; Doyle L; Bonstaff K; Del Valle L; Parsons C; Toole BP; Renne R; Qin Z
Oncotarget; 2016 Mar; 7(9):10459-71. PubMed ID: 26859574
[TBL] [Abstract][Full Text] [Related]
39. Human bcl-2 expression, cleaved caspase-3, and KSHV LANA-1 in Kaposi sarcoma lesions.
Ramos da Silva S; Bacchi MM; Bacchi CE; Elgui de Oliveira D
Am J Clin Pathol; 2007 Nov; 128(5):794-802. PubMed ID: 17951202
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stress.
Qin Z; Freitas E; Sullivan R; Mohan S; Bacelieri R; Branch D; Romano M; Kearney P; Oates J; Plaisance K; Renne R; Kaleeba J; Parsons C
PLoS Pathog; 2010 Jan; 6(1):e1000742. PubMed ID: 20126446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
